HBK Sorce Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$797K Sell
5,919
-53
-0.9% -$6.62K 0.02% 285
2025
Q4
$750K Buy
5,972
+510
+9% +$58.5K 0.02% 285
2025
Q3
$592K Buy
5,462
+21
+0.4% +$1.89K 0.01% 321
2025
Q2
$451K Sell
5,441
-351
-6% -$28K 0.01% 362
2025
Q1
$470K Buy
5,792
+1,310
+29% +$117K 0.01% 353
2024
Q4
$404K Buy
4,482
+279
+7% +$27K 0.01% 385
2024
Q3
$415K Sell
4,203
-119
-3% -$11.7K 0.01% 382
2024
Q2
$401K Sell
4,322
-216
-5% -$19.4K 0.01% 371
2024
Q1
$431K Buy
4,538
+113
+3% +$10.5K 0.02% 368
2023
Q4
$395K Buy
4,425
+267
+6% +$19.8K 0.02% 363
2023
Q3
$304K Buy
4,158
+37
+0.9% +$2.96K 0.01% 417
2023
Q2
$343K Sell
4,121
-25
-0.6% -$2.09K 0.01% 409
2023
Q1
$316K Sell
4,146
-3,450
-45% -$286K 0.01% 423
2022
Q4
$631K Buy
7,596
+3,759
+98% +$304K 0.02% 371
2022
Q3
$304K Buy
3,837
+1,006
+36% +$84.8K 0.02% 361
2022
Q2
$210K Buy
2,831
+308
+12% +$23.1K 0.02% 420
2022
Q1
$227K Buy
2,523
+175
+7% +$16.2K 0.01% 478
2021
Q4
$263K Buy
2,348
+3
+0.1% +$362 0.01% 489
2021
Q3
$295K Sell
2,345
-60
-2% -$7.73K 0.02% 442
2021
Q2
$326K Buy
2,405
+10
+0.4% +$1.31K 0.02% 427
2021
Q1
$325K Buy
2,395
+222
+10% +$33.2K 0.02% 383
2020
Q4
$306K Buy
2,173
+100
+5% +$12.8K 0.02% 368
2020
Q3
$231K Buy
+2,073
New +$232K 0.02% 390
2018
Q4
Sell
-2,331
Closed -$224K 423
2018
Q3
$224K Buy
2,331
+44
+2% +$4.27K 0.03% 356
2018
Q2
$218K Buy
+2,287
New +$210K 0.03% 353

Other funds holding XBI